RxDoctor Payments Data

Theresa Perry, APRN

Psychiatric/Mental Health · Pensacola, FLNPI 1255845392

Payments from drug & device makers

$6,904in general payments, 2019–2025

Across 465 payments — averaging $14.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$956
  • AbbVie$722
  • Lundbeck LLC$692
  • Corium, LLC$555
  • Teva Pharmaceuticals USA, Inc.$535
  • Alkermes, Inc.$437
  • plus $3K from 20 others

What the payments were for

  • Food & beverage$6,79998%
  • Education$1042%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,904 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$15,515
Medicare patients
32
Services billed
155

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl15$36,004
Lurasidone Hcl11$6,127
Vilazodone Hcl23$2,574
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine13$1,677
Bupropion XlBupropion Hcl47$1,008
Duloxetine Hcl30$804
Desvenlafaxine Succinate ErDesvenlafaxine Succinate20$533
Venlafaxine Hcl ErVenlafaxine Hcl11$397
Fluoxetine Hcl46$387
Clonazepam72$387
Prazosin Hcl14$380
Lamotrigine24$370
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine21$338
Quetiapine Fumarate26$321
Trazodone Hcl43$241

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$722$36,00415 claims
Almatica Pharma LLCSertraline Hcl$254$19221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Pensacola

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →